Smith & Nephew is the first and only major medical device company to design, build and distribute this powerful new technology for patients suffering from advanced osteoarthritis of the knee. Other implant makers rely on systems designed and built by third parties.
Smith & Nephew is a global medical technology business, specializing in Orthopaedic Reconstruction, Orthopaedic Trauma & Clinical Therapies, Endoscopy and Advanced Wound Management products. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The company has 8,800 employees and operates in 32 countries around the world. Annual Sales in 2007 were nearly $3.4 billion.
This press release contains certain "forward-looking statements" within
the meaning of the US Private Securities Litigation Reform Act of 1995. In
particular, statements regarding planned growth in our business and in our
trading margins discussed under "Outlook" are forward-looking statements as
are discussions of our product pipeline. These statements, as well as the
phrases "aim", "plan", "intend", "anticipate", "well-placed", "believe",
"estimate", "expect", "target", "consider" and similar expressions, are
generally intended to identify forward-looking statements. Such forward-
looking statements involve known and unknown risks, uncertainties and other
important factors (including, but not limited to, the outcome of litigation
and regulatory approvals) that could cause the actual results, performance or
achievements of Smi
|SOURCE Smith & Nephew, Inc.|
Copyright©2009 PR Newswire.
All rights reserved